Creatine News and Research

RSS

Creatine is an endogenous amino acid which is synthesized from simpler amino acids, namely glycine, arginine and the sulfur-containing amino acid methionine. Approximately 95 percent of creatine in the body is stored in skeletal muscle.

Study answers question of timing in use of eptifibatide

An international study to resolve a decade of debate over the best timing for administering an anti-clotting drug for certain heart patients has come up with an answer: It doesn't matter.

30 Mar 2009

MR spectroscopy may help avoid invasive procedures and treatments for recurrent brain lesions

A clinical decision model which uses MR spectroscopy to help physicians differentiate between recurrent tumors and changes in the brain tissue due to radiation treatments, may help patients avoid invasive procedures and treatments, according to a study performed at the University of Michigan Health System in Ann Arbor, MI.

2 Feb 2009

Nutrition for the growing athlete: The good, the bad and the ugly

For millions of American children and teens playing sports, good nutrition is critical for maximum health, performance and normal growth.

8 May 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008

People with manic depression have a distinct chemical signature in their brains

People with manic depression have a distinct chemical signature in their brains, according to a new study. The research, published in the journal Molecular Psychiatry, may also indicate how the mood stabilisers used to treat the disorder counteract the changes in the brain that it appears to cause.

5 Feb 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008

Creatine in addition to exercise enhances strength in older adults

Lower muscle mass and an increase in body fat are common consequences of growing older.

3 Oct 2007

Lack of sleep leads to increased urinary output and more salt in urine

Our body's production of urine follows a circadian rhythm. During the day, we experience greater urinary frequency; at night, urine production declines, enabling us to get uninterrupted sleep.

9 Aug 2007

Rosuvastatin well tolerated by a broad range of patients with dyslipidemia

The safety and tolerability of rosuvastatin were assessed using data from 16,876 patients who received rosuvastatin 5-40 mg in a multinational phase II/III/IIIb/IV program, representing 25,670 patient-years of continuous exposure to rosuvastatin. An integrated database, consisting of 33 trials whose databases were locked up to and including September 16, 2005, was used to examine adverse events and laboratory data.

9 May 2007

Avicena files composition of matter patent application for treatment of Huntington's disease

Avicena Group has announced day that it has filed a composition of matter patent application with the United States Patent and Trademark Office (USPTO) to cover potential treatments for Huntington's disease, a fatal neurodegenerative disease.

1 May 2007

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.

27 Apr 2007

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Avicena Group has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), a severe neurodegenerative disease.

24 Apr 2007

Researchers look at whether creatine slows progression of Parkinson's disease

Researchers at the University of Rochester Medical Center are leading one of the largest clinical trials ever for Parkinson's disease.

25 Mar 2007

Creatine may help Parkinson's patients by giving an energy boost to dying cells

Whether a supplement used by athletes to boost energy levels and build muscle can slow progression of Parkinson's disease is the focus of a North American study.

22 Mar 2007

Avicena issued U.S. creatine patent

Avicena Group has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,186,754, entitled, "Use of Creatine or Creatine Compounds for Skin Preservation," on March 6, 2007.

8 Mar 2007

Creatine could help people with muscular dystrophies

Creatine, a popular nutritional supplement used by weightlifters and sprinters to improve athletic performance, could lend muscle strength to people with muscular dystrophies.

30 Jan 2007

Redefining myocardial infarction for the 21st century

World Congress of Cardiology Report - Progress in the identification and quantification of biochemical markers of myocardial injury have led to a redefinition of myocardial infarction (MI).

5 Sep 2006

A wake-up call for parents of children with sleep apnea

In what is believed to be the first study showing neural changes in the brains of children with serious, untreated sleep apnea, Johns Hopkins researchers conclude that children with the disorder appear to suffer damage in two brain structures tied to learning ability.

31 Aug 2006

Improving your diet may not help you beat stress

New research shows that some dietary interventions may not prove effective in helping tackle stress and poor health.

10 Jul 2006

Children who are open to experimenting with herbal products may be more open to trying illicit drugs

Adolescents who have ever used herbal products are six times more likely to have tried cocaine and almost 15 times more likely to have used anabolic steroids than teens who have never used herbal products

23 Mar 2006